Renaissance Group’s Veracyte VCYT Stock Holding History

Renaissance Group’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$8.3M	Buy	+180,351	New	+$8.69M	0.36%	77

Other funds holding VCYT

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

GW&K Investment Management Boston, Massachusetts $11.8B AUM 29.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Congress Asset Management Boston, Massachusetts $15.4B AUM 30.39% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 38.25% 1-Year Est. Return

Vaughan Nelson Investment Management Houston, Texas $9.7B AUM 39.07% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Renaissance Group's VCYT Position: Q3 2026 in Review

Renaissance Group opened a new position in Veracyte (VCYT) in Q3 2026: 180,351 shares worth $8.3M. The stake represents 0.36% of the portfolio and ranks #77 among its holdings.

245 funds tracked by Wall St. Rank hold VCYT as of Q3 2026.

Renaissance Group held 180,351 shares of Veracyte worth $8.3M as of Q3 2026.
Veracyte was a new Renaissance Group position in Q3 2026.
Veracyte made up 0.36% of Renaissance Group's portfolio in Q3 2026, its #77 holding.
245 funds tracked by Wall St. Rank held Veracyte as of Q3 2026.

Based on Renaissance Group's 13F filing for Q3 2026, filed 12 Nov 2026.